In this study, we propose that the novel DNAJB9–FBXO45 signaling axis synergistically suppresses the metastatic progression of breast cancer, and the modulation of this network is an effective therapeutic strategy against metastatic TNBC (Fig. 6). The gene discussed is DNAJB9; the disease is breast cancer.